期刊文献+

56例西妥昔单抗联合治疗晚期胃肠恶性肿瘤患者不良反应的观察与护理 被引量:14

Nursing strategies to adverse drug reactions in 56 advanced gastrointestinal cancer patients treated by cetuximab combined with chemotherapy
原文传递
导出
摘要 总结了西妥昔单抗联合化疗治疗晚期胃肠恶性肿瘤患者不良反应的护理要点。针对56例用药后产生的不良反应进行分度比较,通过掌握此类药物的不良反应,并根据轻重程度给予不同的护理方法,所有患者均按时完成了药物治疗。 【Objective】This paper summarizes the nursing strategies to adverse drug reactions in 56 advanced gastrointestinal cancer patients treated by cetuximab combined with chemotherapy.The common adverse drug reactions were graded and proper measures were taken according to the severity.All the patients completed drug treatment as scheduled.
出处 《中华护理杂志》 CSCD 北大核心 2011年第5期461-463,共3页 Chinese Journal of Nursing
关键词 药物疗法 联合 胃肠肿瘤 护理 Drug Therapy Combination Gastrointestinal Neoplasms Nursing Care
  • 相关文献

参考文献10

  • 1Harding J,Burtness B. Cetuximab:an epidermal growth factor receptor chimeric human-murine monoclonal antibody[J]. Drugs Today,2005,41 (2) : 107-127.
  • 2Baselga J. The EGFR as a target for anticancer therapy--focus on ce- tuximab[J]. Eur J Cancer,2001,37(suppl 4):S16-22.
  • 3Therasse P,Arbuck SG,Eisenhauer EA,et al. New guidelines to evalu- ate the response to treatment in solid tumors:European organization for research and treatment of cancer,national cancer institute of the united states,national cancer institute of canada[J]. J Natl Cancer Inst,2000, 92(3) :205-216.
  • 4Trotti A,Colevas AD,Setser A,et al. Development of a comprehensive grading system for the adverse effects of cancer treatment[J]. Semin Radiat Oncol,2003,13(3) : 176-181.
  • 5David K Cetuximab in metastatic colorectal cancer[J]. London Cancer New Drugs Group,2005,7(1 ) : 1-10.
  • 6Cunningham D,Humblet Y,Siena S,et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer[J]. N Engl J Med,200d,351 (g):337-345.
  • 7Huang S,Bock J,Harari P,et al. Epidermal growth factor receptor blockade with C225 modulates proliferation,apoptosis,and radiosensitivi- ty in squamous cell carcinomas of the head and neck[J]. Cancer Res, 1999,59 ( 11 ) : 1935-1940.
  • 8Saltz L,Cox J,Blanke C,et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectsl cancer[J]. N Engl J Med,2000,343(13):905-914.
  • 9开普拓临床研究协作组.开普拓治疗大肠癌的临床应用[J].中华肿瘤杂志,2003,25(6):607-609. 被引量:30
  • 10管忠震,孙晓非,冯奉仪,金懋林,许立功,黄建瑾,冯继峰,隋广杰,谭华.依立替康 (Irinotecan ,CPT -11)治疗晚期大肠癌临床研究[J].癌症,1999,18(6):686-690. 被引量:63

共引文献81

同被引文献82

引证文献14

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部